Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples